Form 8-K - Current report:
SEC Accession No. 0000950170-24-134558
Filing Date
2024-12-09
Accepted
2024-12-09 16:23:17
Documents
11
Period of Report
2024-12-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K achv-20241205.htm   iXBRL 8-K 51343
  Complete submission text file 0000950170-24-134558.txt   207269

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT achv-20241205.xsd EX-101.SCH 51388
13 EXTRACTED XBRL INSTANCE DOCUMENT achv-20241205_htm.xml XML 6342
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 241535389
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)